Truist Financial Begins Coverage on Cabot (NYSE:CBT)

Truist Financial assumed coverage on shares of Cabot (NYSE:CBTGet Free Report) in a research note issued on Monday, MarketBeat Ratings reports. The firm set a “buy” rating and a $98.00 price target on the specialty chemicals company’s stock. Truist Financial’s target price indicates a potential upside of 21.20% from the company’s previous close.

A number of other research analysts have also recently weighed in on CBT. Mizuho lifted their target price on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. increased their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. UBS Group raised their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Wall Street Zen cut Cabot from a “buy” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $83.80.

Check Out Our Latest Stock Analysis on CBT

Cabot Stock Down 0.0%

NYSE CBT opened at $80.86 on Monday. Cabot has a 52 week low of $58.33 and a 52 week high of $89.46. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.17 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 10.67 and a beta of 0.82. The stock’s 50-day moving average price is $79.11 and its 200-day moving average price is $73.09.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. During the same period in the previous year, the company posted $1.90 EPS. The firm’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts predict that Cabot will post 6.32 earnings per share for the current year.

Institutional Trading of Cabot

Hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its holdings in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 299 shares during the last quarter. Torren Management LLC bought a new position in Cabot during the fourth quarter valued at approximately $26,000. Rothschild Investment LLC boosted its stake in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares during the last quarter. Hantz Financial Services Inc. grew its holdings in Cabot by 227.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 298 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Articles

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.